Diabetes 52:138-144, 2003
© 2003 by the American Diabetes Association, Inc.
Intramyocellular Lipid and Insulin Resistance
A Longitudinal In Vivo 1H-Spectroscopic Study in Zucker Diabetic Fatty Rats
Johanna Kuhlmann,
Claudia Neumann-Haefelin,
Ulrich Belz,
Jürgen Kalisch,
Hans-Paul Juretschke,
Marion Stein,
Elke Kleinschmidt,
Werner Kramer, and
Andreas W. Herling
From Aventis Pharma Deutschland, Frankfurt am Main, Germany
Insulin resistance plays an important role in the pathogenesis of human type 2 diabetes. In humans, a negative correlation between insulin sensitivity and intramyocellular lipid (IMCL) content has been shown; thus, IMCL becomes a marker for insulin resistance. Recently, magnetic resonance spectroscopy (MRS) has been established as a dependable method for selective detection and quantification of IMCL in humans. To validate the interrelation between insulin sensitivity and IMCL in an animal model of type 2 diabetes, we established volume selective 1H-MRS at 7 Tesla to noninvasively assess IMCL in the rat. In male obese Zucker Diabetic Fatty rats and their lean littermates, IMCL levels were determined repeatedly over 4 months, and insulin sensitivity was measured by the euglycemic-hyperinsulinemic clamp method at 67 and at 2224 weeks of age. A distinct relation between IMCL and insulin sensitivity was demonstrated as well as age dependence for both parameters. Rosiglitazone treatment caused a clear reduction of IMCL and hepatic fat despite increased body weight, and a marked improvement of insulin sensitivity. Thus, the insulin sensitizing properties of rosiglitazone were consistent with a redistribution of lipids from nonadipocytic (skeletal muscle, liver) back into fat tissue.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. W. Norris, M. F. Hirshman, J. Yao, N. Jessen, N. Musi, L. Chen, W. I. Sivitz, L. J. Goodyear, and C. R. Kahn
Endogenous Peroxisome Proliferator-Activated Receptor-{gamma} Augments Fatty Acid Uptake in Oxidative Muscle
Endocrinology,
November 1, 2008;
149(11):
5374 - 5383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. De Feyter, E. Lenaers, S. M. Houten, P. Schrauwen, M. K. Hesselink, R. J. A. Wanders, K. Nicolay, and J. J. Prompers
Increased intramyocellular lipid content but normal skeletal muscle mitochondrial oxidative capacity throughout the pathogenesis of type 2 diabetes
FASEB J,
November 1, 2008;
22(11):
3947 - 3955.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Hausman, S. P. Poulos, T. D. Pringle, and M. J. Azain
The influence of thiazolidinediones on adipogenesis in vitro and in vivo: Potential modifiers of intramuscular adipose tissue deposition in meat animals
J Anim Sci,
April 1, 2008;
86(14_suppl):
E236 - E243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Gounarides, M. Korach-Andre, K. Killary, G. Argentieri, O. Turner, and D. Laurent
Effect of Dexamethasone on Glucose Tolerance and Fat Metabolism in a Diet-Induced Obesity Mouse Model
Endocrinology,
February 1, 2008;
149(2):
758 - 766.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Aslanidi, V. Kroutov, G. Philipsberg, K. Lamb, M. Campbell-Thompson, G. A. Walter, S. Kurenov, J. Ignacio Aguirre, P. Keller, K. Hankenson, et al.
Ectopic expression of Wnt10b decreases adiposity and improves glucose homeostasis in obese rats
Am J Physiol Endocrinol Metab,
September 1, 2007;
293(3):
E726 - E736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Roy, S. Bhardwaj, M. Babu, I. Kokina, S. Uotila, T. Ahtialansaari, T. Laitinen, J. Hakumaki, M. Laakso, K.-H. Herzig, et al.
VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NF-{kappa}B, and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits
FASEB J,
October 1, 2006;
20(12):
2159 - 2161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. L. Wang, L. Zhang, K. Youker, M.-X. Zhang, J. Wang, S. A. LeMaire, J. S. Coselli, and Y. H. Shen
Free Fatty Acids Inhibit Insulin Signaling-Stimulated Endothelial Nitric Oxide Synthase Activation Through Upregulating PTEN or Inhibiting Akt Kinase.
Diabetes,
August 1, 2006;
55(8):
2301 - 2310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Nadeau, L. B. Ehlers, L. E. Aguirre, R. L. Moore, K. N. Jew, H. K. Ortmeyer, B. C. Hansen, J. E. B. Reusch, and B. Draznin
Exercise training and calorie restriction increase SREBP-1 expression and intramuscular triglyceride in skeletal muscle
Am J Physiol Endocrinol Metab,
July 1, 2006;
291(1):
E90 - E98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Beha, H.-P. Juretschke, J. Kuhlmann, C. Neumann-Haefelin, U. Belz, M. Gerl, W. Kramer, M. Roden, and A. W. Herling
Muscle type-specific fatty acid metabolism in insulin resistance: an integrated in vivo study in Zucker diabetic fatty rats
Am J Physiol Endocrinol Metab,
May 1, 2006;
290(5):
E989 - E997.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Korach-Andre, J. Gao, J. S. Gounarides, R. Deacon, A. Islam, and D. Laurent
Relationship between visceral adiposity and intramyocellular lipid content in two rat models of insulin resistance
Am J Physiol Endocrinol Metab,
January 1, 2005;
288(1):
E106 - E116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Lessard, S. L. L. Giudice, W. Lau, J. J. Reid, N. Turner, M. A. Febbraio, J. A. Hawley, and M. J. Watt
Rosiglitazone Enhances Glucose Tolerance by Mechanisms Other than Reduction of Fatty Acid Accumulation within Skeletal Muscle
Endocrinology,
December 1, 2004;
145(12):
5665 - 5670.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Nadeau, J. W. Leitner, I. Gurerich, and B. Draznin
Insulin Regulation of Sterol Regulatory Element-binding Protein-1 Expression in L-6 Muscle Cells and 3T3 L1 Adipocytes
J. Biol. Chem.,
August 13, 2004;
279(33):
34380 - 34387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Schoelch, J. Kuhlmann, M. Gossel, G. Mueller, C. Neumann-Haefelin, U. Belz, J. Kalisch, G. Biemer-Daub, W. Kramer, H.-P. Juretschke, et al.
Characterization of Adenosine-A1 Receptor-Mediated Antilipolysis in Rats by Tissue Microdialysis, 1H-Spectroscopy, and Glucose Clamp Studies
Diabetes,
July 1, 2004;
53(7):
1920 - 1926.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Buettner, I. Ottinger, J. Scholmerich, and L. C. Bollheimer
Preserved direct hepatic insulin action in rats with diet-induced hepatic steatosis
Am J Physiol Endocrinol Metab,
May 1, 2004;
286(5):
E828 - E833.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Neumann-Haefelin, A. Beha, J. Kuhlmann, U. Belz, M. Gerl, M. Quint, G. Biemer-Daub, M. Broenstrup, M. Stein, E. Kleinschmidt, et al.
Muscle-Type Specific Intramyocellular and Hepatic Lipid Metabolism During Starvation in Wistar Rats
Diabetes,
March 1, 2004;
53(3):
528 - 534.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Diabetes Association.
|
|
| |
|